Asis Pharmaceuticals. (2021). Nitrofurantoin 100mg Capsules. Electronic Medicines Compendium (EMC). Retrieved 1 April 2024, from https://www.medicines.org.uk/emc/files/pil.13236.pdf
FDA. (2021). Macrodantin® (Nitrofurantoin Capsules, USP). Retrieved 1 April 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016620Orig1s076lbl.pdf
Huttner, A., Verhaegh, E. M., Harbarth, S., Muller, A. E., Theuretzbacher, U., & Mouton, J. W. (2015). Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. Journal of Antimicrobial Chemotherapy, 70(9), 2456-2464. https://doi.org/10.1093/jac/dkv147
MedlinePlus. (2021). Nitrofurantoin. Retrieved 1 April 2024, from https://medlineplus.gov/druginfo/meds/a682291.html
Meiji Pharma Spain. (2021). Nitrofurantoin 100mg Capsules. Health Products Regulatory Authority (HPRA). Retrieved 1 April 2024, from https://www.hpra.ie/img/uploaded/swedocuments/3a92db31-ada9-46ed-abc6-f4c67161c564.pdf
Squadrito, F. J., & del Portal, D. (2021). Nitrofurantoin. In StatPearls [Internet]. Retrieved 1 April 2024, from https://www.ncbi.nlm.nih.gov/books/NBK470526/
Tripathi, K. D. (2019). Essentials of medical pharmacology (8th ed.). Jaypee Brothers Medical Publishers (P) Ltd.
Cimolai, N., & Cimolai, T. (2007). Nitrofurantoin and pregnancy. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 176(13), 1860–1861. https://doi.org/10.1503/cmaj.1070028
Zao, J., Koren, G., & Bozzo, P. (2014). Using nitrofurantoin while breastfeeding a newborn. Canadian family physician Medecin de famille canadien, 60(6), 539–540.
Mergenhagen, K. A., Wattengel, B. A., Skelly, M. K., Clark, C. M., & Russo, T. A. (2020). Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions. Antimicrobial agents and chemotherapy, 64(3), e02167-19. https://doi.org/10.1128/AAC.02167-19
Luk, T., Edwards, B. D., Bates, D., Evernden, C., & Edwards, J. (2021). Nitrofurantoin-induced liver failure: A fatal yet forgotten complication. Canadian family physician Medecin de famille canadien, 67(5), 342–344. https://doi.org/10.46747/cfp.6705342
Singh, N., Gandhi, S., McArthur, E., Moist, L., Jain, A. K., Liu, A. R., Sood, M. M., & Garg, A. X. (2015). Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 187(9), 648–656. https://doi.org/10.1503/cmaj.150067
Bhatt, C., Doleeb, Z., Bapat, P., & Pagnoux, C. (2023). Drug-induced haemolysis: another reason to be cautious with nitrofurantoin. BMJ case reports, 16(1), e251119. https://doi.org/10.1136/bcr-2022-251119
White, W. T., Harrison, L., & Dumas, J., 2nd (1984). Nitrofurantoin unmasking peripheral neuropathy in a type 2 diabetic patient. Archives of internal medicine, 144(4), 821.